NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/04/2024
Back to search
Official data from USPTO
LYPRINOL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
04/04/2024
Trademark type
Word
Nice classes
5
Filing date
09/20/2002
Registration date
01/20/2004
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/04/2024
Last transaction
04/04/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
Drawing code
1
Owner type
16
Owner location
Central Hong Kong, HK
Examiner
GARTNER, JOHN M
Law office
L20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Pharmalink International Limited
Pharmalink International Limited
Representatives
Elizabeth A. Cominolli Markert & Cominolli PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of inflammatory conditionsnamely rheumatoid and osteoarthritisasthmapsoriasiscolitislupuscardio inflammationinflammation of limbs resulting from injury; natural medicines containing extracts of shell fish and omega fatty acidspain relief medication
Publications
History of USPTO decisions and trademark events.
31 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
04/04/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/04/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/02/2024
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
03/27/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/27/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
11/02/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/20/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/28/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/28/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/28/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/28/2013
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
12/17/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
12/17/2013
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
09/30/2011
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/28/2011
ES7R
TEAS SECTION 7 REQUEST RECEIVED
09/27/2011
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/04/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/04/2010
E815
TEAS SECTION 8 & 15 RECEIVED
12/23/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
01/20/2004
PUBO
PUBLISHED FOR OPPOSITION
10/28/2003
NPUB
NOTICE OF PUBLICATION
10/08/2003
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/05/2003
CFIT
CASE FILE IN TICRS
08/27/2003
1.BD
Sec. 1(B) CLAIM DELETED
08/07/2003
PAPER RECEIVED
08/07/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/06/2003
GNRT
NON-FINAL ACTION E-MAILED
02/15/2003
DOCK
ASSIGNED TO EXAMINER
02/14/2003
PAPER RECEIVED
10/24/2002
Continuous trademark protection
Get notified about every new filing that threatens LYPRINOL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.